FdaApplication
BLA 103779
Identifiers
- fda_app_no: BLA103779
Properties
| Property | Value |
|---|---|
| applicant_name | Wyeth Pharmaceuticals LLC |
| application_type | BLA |
| approval_date | 2001-06-27 |
Revenue by product
REFACTO
| Period | Revenue |
|---|---|
| FY 2023 | $230.0M |
| FY 2022 | $239.0M |
| FY 2021 | $304.0M |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients.
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REFACTO | — | 250IU | For Injection |
| REFACTO | — | 1000IU | For Injection |
| REFACTO | — | 500IU | For Injection |
| REFACTO | — | 2000IU | For Injection |
4 products